2021年7月20日，咸亨国际在上交所主板上市，发行数量为4001.00万股（本次发行股份全部为新股，无 老股转让），发行价格为13.65元/股，保荐机构为海通证券股份有限公司（现更名为国泰海通证券股份 有限公司），保荐代表人为陈金林、饶宇。咸亨国际本次发行募集资金总额为5.46亿元，扣除发行费用 后，募集资金净额为4.75亿元。 咸亨国际于2021年6月17日披露的招股书显示，公司拟募集资金4.75亿元，分别用于海宁生产基地产业 化建设项目、信息化升级及总部基地建设项目、赛孚城应急体验馆及技术服务网络建设项目、研发中心 建设项目、补充流动资金。 中国经济网北京2月6日讯 咸亨国际（605056）(605056.SH)昨晚发布的股东减持股份计划公告显示，公 司于2026年2月5日收到各有限合伙企业发来的《关于减持计划的告知函》。 有限合伙企业出于自身资金需要，拟通过集中竞价和大宗交易方式减持所持有的公司股票，合计减持数 量不超过12,281,793股，即不超过公司总股本的3%。其中：拟通过集中竞价方式减持公司股份不超过 4,093,931股（约占公司总股本比例的1%）；拟通过大宗交易方式减持公司股份不超过8, ...

2021年7月20日，咸亨国际在上交所主板上市，发行数量为4001.00万股（本次发行股份全部为新 股，无老股转让），发行价格为13.65元/股，保荐机构为海通证券股份有限公司（现更名为国泰海通证 券股份有限公司），保荐代表人为陈金林、饶宇。咸亨国际本次发行募集资金总额为5.46亿元，扣除发 行费用后，募集资金净额为4.75亿元。 咸亨国际于2021年6月17日披露的招股书显示，公司拟募集资金4.75亿元，分别用于海宁生产基地 产业化建设项目、信息化升级及总部基地建设项目、赛孚城应急体验馆及技术服务网络建设项目、研发 中心建设项目、补充流动资金。 咸亨国际公开发行新股的发行费用（不含税）为7153.64万元，其中保荐机构海通证券股份有限公 司获得保荐及承销费用4106.94万元，天健会计师事务所（特殊普通合伙）获得审计及验资费用1636.79 万元，北京国枫律师事务所获得律师费用801.89万元。 截至公告日，杭州咸宁投资合伙企业（有限合伙）（以下简称"咸宁"）持有公司无限售条件流通股 58,908,746股，占公司总股本的14.39%。上述股份来源于公司首次公开发行前取得。杭州万宁投资合伙 企业（有限合伙） ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：605056 证券简称：咸亨国际 公告编号：2026-008 咸亨国际科技股份有限公司股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 股东持股的基本情况 截至本公告日，杭州咸宁投资合伙企业（有限合伙）（以下简称"咸宁"）持有咸亨国际科技股份有限公 司（以下简称"公司"）无限售条件流通股58,908,746 股，占公司总股本的14.39%。上述股份来源于公司 首次公开发行前取得。 截至本公告日，杭州万宁投资合伙企业（有限合伙）（以下简称"万宁"）持有公司无限售条件流通股 29,250,214股，占公司总股本的7.14%。上述股份来源于公司首次公开发行前取得。 截至本公告日，杭州弘宁投资合伙企业（有限合伙）（以下简称"弘宁"）持有公司无限售条件流通股 23,167,225股，占公司总股本的5.66%。上述股份来源于公司首次公开发行前取得。 截至本公告日，杭州德宁投资合伙企业（有限合伙）（以下简称"德宁"）持有公司无限售条 ...

Mergers and Acquisitions - Jianhui Information plans to acquire 38% equity of Boke Guoxin (Wuhan) Technology Co., Ltd. for RMB 73.71 million, increasing its stake from 32% to 70%, making it a controlling subsidiary [1] - Tianqimo is planning to acquire equity in Dongshi Automotive Technology Group Co., Ltd. through a combination of issuing shares and cash payments, while also raising supporting funds [2] - Jiangfeng Electronics intends to acquire 15.64% of Kaide Quartz for RMB 448 million, with related parties also purchasing shares, resulting in Jiangfeng becoming the controlling shareholder [3] Shareholding Changes - Beijia Clean has multiple shareholders planning to reduce their holdings by a total of up to 2.9926%, with specific reductions from various entities [4] - Kangpeng Technology announced that shareholders plan to collectively reduce their holdings by up to 5.22%, with specific amounts and percentages detailed for each shareholder [5] - Xianheng International reported that several shareholders intend to reduce their holdings by up to 3%, totaling 1,228,180 shares [6] Risk Matters - *ST Zhengping received a regulatory letter from the Shanghai Stock Exchange regarding its 2025 performance forecast, indicating expected revenue over RMB 300 million but a net loss, with concerns raised by the annual auditor [7] - Beiqing Song's actual controller, Ma Xuejun, is under investigation for alleged market manipulation, although it is stated that this will not significantly impact the company's daily operations [8][9] - *ST Lifang announced a risk of rapid stock price decline and will suspend trading for verification, marking its third suspension this year, with a recent closing price of RMB 2.78 and a market cap of approximately RMB 1.8 billion [10]

Core Viewpoint - On February 5, no A-share listed companies disclosed any increase in shareholding, while eight companies announced share reductions [1][3]. Group 1: Companies with Share Reductions - Sanfengsi: Chairman Ren Min and former supervisor Qiu Honggang plan to reduce their holdings by no more than 0.31% [2][4]. - Longkun Technology: Some directors and senior management personnel plan to reduce their shareholdings [2][4]. - Xianglu Tungsten: Guoan Fund completed its reduction plan, having reduced a total of 1.6 million shares [2][4]. - Sanjiang Shopping: Alizetai reduced its holdings by 4.7883 million shares from January 29 to February 5 [2][4]. - Beijiajie: Xiaobei No. 1, Xiaobei No. 2, and directors and supervisors plan to reduce their holdings by no more than 2.99% [2][4]. - Zhongfu Industrial: Some directors and senior management personnel plan to reduce their shareholdings [2][4]. - Kangpeng Technology: Shareholders plan to reduce their holdings [2][4]. - Xianheng International: One of the actual controllers and their concerted actors plan to reduce their holdings by no more than 3% [2][4].

Group 1 - Zhenghe Ecology signed a strategic cooperation agreement with the government of Miyun District, Beijing, to provide comprehensive services in water safety, resources, ecology, and technology [2] - GCL-Poly Energy announced that it has not yet received any orders in the "space photovoltaic" sector, which remains in the technical exploration stage with uncertain commercial prospects [3] - Changxin Bochuang's shareholder Zhu Wei terminated the transfer of 5.04% of the company's shares, retaining a total of 7.16% of the company's shares [4] - Tianqimo is planning to acquire equity in Dongshi Automotive Technology Group through a combination of share issuance and cash payment, leading to a suspension of trading [5] Group 2 - Hengwei Technology reported a net profit of 34.938 million yuan for 2025, a year-on-year increase of 30.13%, despite a revenue decline of 6.31% to 1.047 billion yuan [7] - Xianheng International's controlling shareholder and associated parties plan to reduce their holdings by up to 3% of the company's shares [9] - Kangpeng Technology's shareholder Wuxi Yunhui intends to reduce its stake by up to 2.94%, while two other shareholders plan to collectively reduce their holdings by up to 2.28% [10] Group 3 - Southeast Network Framework won a bid for an EPC project worth 994 million yuan [12] - Rongfa Nuclear Power's wholly-owned subsidiary won a project from China General Nuclear Power Corporation valued at 101 million yuan [13] - Taiji Industry's subsidiary is expected to win a bid for the Huahong FAB9B project with a bid amount of 3.778 billion yuan [14]

Group 1 - Company Jianhui Information plans to acquire 38% equity in Boke Guoxin for RMB 73.71 million, increasing its stake from 32% to 70%, making Boke Guoxin a subsidiary [1] - Company Guangshengtang's innovative drug GST-HG141 for hepatitis B has completed the enrollment of 578 participants in its Phase III clinical trial [2] - Company Hongjing Optoelectronics is establishing a partnership with a target scale of RMB 290 million, contributing RMB 3 million as a limited partner [3] Group 2 - Company Hongchang Technology intends to acquire 21% equity in Liangzhi Joint, which will make it the controlling shareholder with a 51% stake [4] - Company Xiexin Integrated has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory phase [5] - Company Xianheng International plans to reduce its shareholding by up to 3%, amounting to a maximum of 12.28 million shares [6] Group 3 - Company Furuijia plans to reduce its repurchased shares by up to 2%, totaling 18.93 million shares [7] - Company Tianqimo is planning to issue shares and pay cash to acquire assets, leading to a temporary suspension of its stock [8] - Company Shuangqiang Technology's director plans to reduce his holdings by up to 0.32% [9] Group 4 - Company Bairun plans to adjust the conversion price of its bonds due to stock prices falling below 85% of the conversion price [11] - Company Dongnan Network has won an EPC project worth RMB 994 million [12] - Company Anhui Energy has appointed Xu Wengong as the new general manager following the resignation of Fang Shiqing [13] Group 5 - Company Lijun plans to invest up to USD 3 million to establish subsidiaries in Hong Kong and Peru [14] - Company Zhenghe Ecology has signed a strategic cooperation agreement with the government of Beijing's Miyun District [15] - Company First Venture has elected Guo Chuan as the chairman of its board [16] Group 6 - Company Changxin Bochuang's shareholder has terminated an agreement to transfer 14.5 million shares [17] - Company Hengrui Medicine's HR091506 tablet application has been accepted by the National Medical Products Administration [18] - Company Hengrui Medicine's SHR-1894 injection has received approval for clinical trials [20] Group 7 - Company Longshen Rongfa has obtained a medical device production license [21] - Company Western Securities reported that its new borrowings exceeded 20% of its net assets [22] - Company Rongfa Nuclear Power's subsidiary has won a project worth RMB 101 million [23] Group 8 - Company Taiji Industry's subsidiary has a pre-bid for the Huahong FAB9B project with a bid amount of RMB 3.778 billion [24] - Company Suzhou High-tech plans to increase its investment in a subsidiary by RMB 780 million through a debt-to-equity swap [26] - Company Electric Power Investment's vice president has resigned due to work changes [27] Group 9 - Company Hengwei Technology reported a 30.13% increase in net profit for 2025 [28] - Company Fangsheng Pharmaceutical's subsidiary has received a drug production license [29] - Company Pilin Bio's subsidiary has received a notice for clinical trial acceptance for a hemostatic drug [31] Group 10 - Company Zhongxin Fluorine Material has received approval for a stock issuance to specific investors [32] - Company Shanhe Intelligent expects a total transaction amount with related parties to be RMB 1.197 billion in 2026 [33] - Company Warner Pharmaceutical's partner has completed Phase I clinical trials for a new drug [34]

咸亨国际（605056）(605056.SH)发布公告，公司股东"咸宁"、"万宁"、"弘宁"、"德宁"和"易宁"，出于 自身资金需要，拟通过集中竞价和大宗交易方式减持所持有的公司股票，合计减持数量不超过1228.18 万股，即不超过公司总股本的3%。 ...

1、通过集中竞价方式减持公司股份的，拟于本公告披露之日15个交易日后的3个月内（即2026年3月10 日-2026年6月9日）进行，且在任意连续90个自然日内，减持股份总数不超过公司总股本的1%；2、通 过大宗交易方式减持公司股份的，拟于本公告披露之日起15个交易日后的3个月内（即2026年3月10 日-2026年6月9日）进行，且在任意连续90个自然日内，减持股份总数不超过公司股本总数的2%；前述 减持价格根据减持时市场价格确定。 格隆汇2月5日丨咸亨国际(605056.SH)公布，公司于2026年2月5日收到各有限合伙企业发来的《关于减 持计划的告知函》，"咸宁"、"万宁"、"弘宁"、"德宁"和"易宁"合称"有限合伙企业"。有限合伙企业出 于自身资金需要，拟通过集中竞价和大宗交易方式减持所持有的公司股票，合计减持数量不超过 1228.18万股，即不超过公司总股本的3%。其中：拟通过集中竞价方式减持公司股份不超过409.39万股 （约占公司总股本比例的1%）；拟通过大宗交易方式减持公司股份不超过818.79万股（约占公司总股 本比例的2%）。具体情况如下： ...

智通财经APP讯，咸亨国际(605056.SH)发布公告，公司股东"咸宁"、"万宁"、"弘宁"、"德宁"和"易 宁"，出于自身资金需要，拟通过集中竞价和大宗交易方式减持所持有的公司股票，合计减持数量不超 过1228.18万股，即不超过公司总股本的3%。 ...